Moreover, the identification of ZMAT3 as a novel senescence marker provides a potential valuable tool for future research and clinical applications aimed at targeting SkM senescence to prevent age- and obesity-related metabolic diseases. This evidence concerns the gene ZMAT3 and Other metabolic disease.